Repository logo
 
Publication

Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe [Letters to the Editor]

2016-10-15Periodical Open access
Simple item page
dc.contributor.authorLange, Christoph
dc.contributor.authorDuarte, Raquel
dc.contributor.authorFréchet-Jachym, Mathilde
dc.contributor.authorGuenther, Gunar
dc.contributor.authorGuglielmetti, Lorenzo
dc.contributor.authorOlaru, Ioana D
dc.contributor.authorOliveira, Olena
dc.contributor.authorRumetshofer, Rudolf
dc.contributor.authorVeziris, Nicolas
dc.contributor.authorvan Leth, Frank
dc.contributor.authorEuropean MDR-TB database collaboration
dc.date.accessioned2022-02-04T16:44:49Z
dc.date.available2022-02-04T16:44:49Z
dc.date.issued2016-10-15
dc.descriptionEuropean MDR-TB database collaboration: Sofia Alexandru, Neus Altet, Korkut Avsar, Didi Bang, Raisa Barbuta, Graham Bothamley, Ana Ciobanu, Valeriu Crudu, Manfred Danilovits, Martin Dedicoat, Raquel Duarte, Mathilde Fréchet-Jachym, Gina Gualano, Lorenzo Guglielmetti, Gunar Günther, Jan Heyckendorf, Barbara Kalsdorf, Heinke Kunst, Christoph Lange, Wiel de Lange, Damien Le Dû, Vaira Leimane, Frank van Leth, Rita Macedo, Cecile Magis-Escurra, Anne-Marie McLaughlin, Inge Muylle, Ioana D Olaru, Olena Oliveira, Veronika Polcová, Emanuele Pontali, Cristina Popa, Jérôme Robert, Rudolf Rumetshofer, Alena Skrahina, Varvara Solodovnikova, Victor Spinu, Simon Tiberi, Nicolas Veziris, Piret Viiklepppt_PT
dc.descriptionEuropean MDR-TB database collaboration: Rita Macedo, INSA, Portugalpt_PT
dc.description[Letters to the Editor]pt_PT
dc.description.abstractExtract: The emergence of multidrug-resistant tuberculosis (MDR-TB), defined as bacillary resistance to at least rifampicin and isoniazid, threatens global TB control. The number of patients notified with MDR-TB worldwide has increased by 261% from 2009 to 2014, and more than one-third of these patients currently live in the European Region of the World Health Organization (WHO). Management of patients with MDR-TB is challenging owing to the long duration of therapy required to achieve a relapse-free cure, complex drug regimens, frequent drug-related adverse events, high costs, suboptimal adherence, and overall low cure rates. [...]pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationAm J Respir Crit Care Med. 2016 Oct 15;194(8):1029-1031. doi: 10.1164/rccm.201606-1097LE.pt_PT
dc.identifier.doi10.1164/rccm.201606-1097LEpt_PT
dc.identifier.issn1073-449X
dc.identifier.urihttp://hdl.handle.net/10400.18/7935
dc.language.isoengpt_PT
dc.publisherAmerican Thoracic Societypt_PT
dc.relation.publisherversionhttps://www.atsjournals.org/doi/pdf/10.1164/rccm.201606-1097LEpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectAntitubercular Agentspt_PT
dc.subjectClinical Protocolspt_PT
dc.subjectDrug Administration Schedulept_PT
dc.subjectEligibility Determinationpt_PT
dc.subjectEuropept_PT
dc.subjectHumanspt_PT
dc.subjectTreatment Outcomept_PT
dc.subjectTuberculosis, Multidrug-Resistantpt_PT
dc.subjectWorld Health Organizationpt_PT
dc.subjectPractice Guidelines as Topicpt_PT
dc.subjectInfecções Respiratóriaspt_PT
dc.titleLimited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe [Letters to the Editor]pt_PT
dc.typeperiodical
dspace.entity.typePublication
oaire.citation.endPage1031pt_PT
oaire.citation.issue8pt_PT
oaire.citation.startPage1029pt_PT
oaire.citation.titleAmerican Journal of Respiratory and Critical Care Medicinept_PT
oaire.citation.volume194pt_PT
rcaap.embargofctAcesso de acordo com página web do editor da revista.pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typecontributionToPeriodicalpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Acesso embargado.docx
Size:
11.32 KB
Format:
Microsoft Word XML
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DDI - Artigos em revistas internacionais